Heartseed has many unique technologies necessary to spread myocardial regenerative medicine, such as the technology to create high-purity cardiomyocytes from iPS cells and the technology to transplant the created cardiomyocytes. We have received the “Minister of Science and Technology Policy Award” at the Japan Venture Awards 2021 and the “Minister of Education, Culture, Sports, Science, and Technology Award” at the University Venture Awards 2021. We also have a track record of alliances with major overseas pharmaceutical companies.